You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

249 Results
Drug
Other Name(s): Zometa®
Feb 2024
Drug
Other Name(s): Tomudex®
Sep 2024
Drug
Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™
Jun 2025
Drug
Other Name(s): Jakavi®
Mar 2025
Drug
Other Name(s): Stivarga®
Nov 2023
Drug
Other Name(s): Istodax®
Mar 2023
Drug
Other Name(s): Cyramza®
Mar 2023
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Apr 2023
Regimen
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Palliative
Apr 2023
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Apr 2023
Regimen
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma
Jun 2025

Pages